國家衛生研究院 NHRI:Item 3990099045/11105
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 912396      Online Users : 1193
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/11105


    Title: Patterns of interindividual variability in the antibody repertoire targeting proteins across the Epstein-Barr virus proteome
    Authors: Liu, Z;Coghill, AE;Pfeiffer, RM;Proietti, C;Hsu, WL;Chien, YC;Lekieffre, L;Krause, L;Yu, KJ;Lou, PJ;Wang, CP;Mulvenna, J;Middeldorp, JM;Bethony, J;Chen, CJ;Doolan, DL;Hildesheim, A
    Contributors: National Institute of Cancer Research
    Abstract: Background: Little is known about variation in antibody response targeting the full spectrum of Epstein-Barr virus (EBV) proteins and how such patterns inform disease risk. Methods: We utilized a microarray to measure IgG and IgA antibody responses against 199 EBV protein sequences from five EBV strains in 289 healthy adults from Taiwan. We described positivity patterns, estimated the correlation between antibodies, and investigated the association between environmental and genetic risk factors and variation in antibody responses. Results: Healthy adults were more likely to mount IgG antibody responses to EBV proteins (median IgG vs. IgA positivity rate: 46.5% vs. 17.3%, Prank-test = 1.6 x 10-46). Responses against glycoproteins were particularly prevalent. The correlations between antibody responses of the same class were higher than correlations across class. The mucosal exposure (IgA response) to proteins involved in EBV reactivation was associated with smoking (PSKAT-C= 0.002), and approximately one quarter of adults displayed antibody responses associated with EBV-related cancer risk. Conclusions: These data comprehensively define the variability in human IgG and IgA antibody response to the EBV proteome. Patterns observed can serve as the foundation for elucidating which individuals are at highest risk of EBV-associated clinical conditions and identifying targets for effective immunodiagnostics.
    Date: 2018-06
    Relation: Journal of Infectious Diseases. 2018 Jun;217(12):1923-1931.
    Link to: http://dx.doi.org/10.1093/infdis/jiy122
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0022-1899&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000434082000013
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85048142802
    Appears in Collections:[Others] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    PUB29509907.pdf5489KbAdobe PDF141View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback